Procter & Gamble Hygiene and Health Care (BOM:500459) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


BOM:500459 Procter & Gamble Hygiene and Health Care Ltd BOM:500459
79 GF Score
Price ₹8,970.80
GF Value ₹15,977.32
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Procter & Gamble Hygiene and Health Care Research & Development?

Procter & Gamble Hygiene and Health Care BOM:500459 -0.67% 79 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:500459 with a GF Score™ of 79/100 and a GF Value™ of ₹15,977.32 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Procter & Gamble Hygiene and Health Care's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Procter & Gamble Hygiene and Health Care  (BOM:500459) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Procter & Gamble Hygiene and Health Care Research & Development Related Terms

Procter & Gamble Hygiene and Health Care Research & Development Historical Data

* Premium members only.

The historical data trend for Procter & Gamble Hygiene and Health Care's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Procter & Gamble Hygiene and Health Care Research & Development Chart

Procter & Gamble Hygiene and Health Care Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Procter & Gamble Hygiene and Health Care Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:500459
79GF Score
Procter & Gamble Hygiene and Health Care Ltd BOM:500459
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Procter & Gamble Hygiene and Health Care Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Procter & Gamble Hygiene and Health Care (BOM:500459) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Procter & Gamble Hygiene and Health Care and its competitors.
Is Procter & Gamble Hygiene and Health Care's Research & Development too high?
Procter & Gamble Hygiene and Health Care's current Research & Development is ₹0 Mil. Overall, Procter & Gamble Hygiene and Health Care has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Procter & Gamble Hygiene and Health Care's Research & Development compare to PG and CL?
Procter & Gamble Hygiene and Health Care's Research & Development of ₹0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Procter & Gamble Hygiene and Health Care and its competitors. Procter & Gamble Hygiene and Health Care's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procter & Gamble Hygiene and Health Care stock overvalued right now?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care (BOM:500459) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹15,977.32, compared to a current price of ₹8,970.80 — trading 43.9% below its estimated fair value. The current Research & Development is ₹0 Mil. Procter & Gamble Hygiene and Health Care's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Procter & Gamble Hygiene and Health Care (BOM:500459), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Procter & Gamble Hygiene and Health Care (BOM:500459) Overvalued in 2026?

Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care stock appears to be undervalued. The current stock price of ₹8,970.80 is trading 43.9% below its estimated GF Value™ of ₹15,977.32. GuruFocus considers Procter & Gamble Hygiene and Health Care to be Significantly Undervalued.

Key valuation signals for BOM:500459:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹15,977.32 vs. price of ₹8,970.80 (43.9% below fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the BOM:500459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Procter & Gamble Hygiene and Health Care Business Description

Other Exchanges PGHH:India
Address Cardinal Gracias Road, P&G Plaza, Chakala, Andheri (East), Mumbai, MH, IND, 400099
Procter & Gamble Hygiene and Health Care Ltd is an Indian company engaged in the manufacturing and selling of feminine hygiene care and healthcare products. The portfolio includes brands like Ambi Pur, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide Ariel, Duracell, Gillette, Vicks, and Wella. The business is divided into a feminine hygiene business and a healthcare business. The feminine hygiene business offers sanitary napkins and feminine sanitary hygiene products; its popular brand is Whisper. The healthcare business offers creams, cough drops, and other health products. The company distributes its products through various channels: from retail locations such as mass merchandizers and grocery stores, to drug stores and department stores.
79GF Score

Get the complete analysis for BOM:500459

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8,970.80
Price
₹15,977.32
GF Value